Allē Double Point Promotion Encourages
Consumers to See the JUVÉDERM® Difference
IRVINE,
Calif., Aug. 17, 2022 /PRNewswire/ -- Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), invites consumers
to experience the JUVÉDERM® difference. The
JUVÉDERM® Collection of Fillers is the number one
selling collection of dermal fillers on the market and offers the
largest portfolio of fillers specifically designed for different
areas of the face to address key patient concerns, enabling a
customized treatment approach.1 Injectable dermal
fillers are highly sought-after treatments among consumers who are
looking to address key signs of aging or to simply accentuate what
is already naturally theirs.
![The JUVÉDERM® Collection of Fillers The JUVÉDERM® Collection of Fillers](https://mma.prnewswire.com/media/1879829/JUVEDERM_Fillers.jpg)
Right now, consumers can earn double points in Allē, Allergan
Aesthetics' loyalty rewards program, when treated with two or three
syringes from the JUVÉDERM® Collection of Fillers during
the same visit. Allē points can be redeemed for future
Allē-eligible treatments or products. The promotion runs through
Friday, September 30, 2022. Allē
members can also use the Allē Flash program to determine if they
are eligible for additional savings.
"We estimate that in the U.S., 20 million consumers are
interested in receiving treatment with a dermal filler in the next
two years.2 We help support and grow the filler market
while ensuring that all consumers who are interested in talking to
their specialist about treatment with the
JUVÉDERM® Collection of Fillers have access to
education and the product. Recently, we launched a YouTube channel
to provide deeper patient education and it has more than five
million views since launch," said Carrie
Strom, Global President Allergan Aesthetics. "The
JUVÉDERM® Collection of Fillers is the number one chosen
dermal filler collection in the U.S. and approved for all skin
tones.1, 3-5 We are excited to share our passion for the
JUVÉDERM® Collection of Fillers with consumers through
this limited time offer. We invite them to talk to their specialist
and experience the JUVÉDERM® difference for
themselves."
The JUVÉDERM® difference is achieved with a wide
range of minimally invasive treatment options that provides instant
results that are long-lasting and natural-looking.6-12
Additionally, the JUVÉDERM® Collection of Fillers'
VYCROSS® technology is the number one chosen dermal
filler technology worldwide.1 As the number one chosen
dermal filler collection worldwide, JUVÉDERM® boasts the
top chosen fillers for cheeks (JUVÉDERM®
VOLUMA® XC), lower face wrinkles and folds
(JUVÉDERM® Ultra Plus XC and JUVÉDERM®
VOLLURE® XC), lips (JUVÉDERM® Ultra XC and
JUVÉDERM® VOLBELLA® XC), and perioral lines
(JUVÉDERM® VOLBELLA® XC).1
"I use the full JUVÉDERM® Collection of Fillers to
achieve optimal aesthetic outcomes for my patients," said Dr.
Deborah Sherman, board certified,
fellowship trained ophthalmic plastic surgeon and master
injector. "As one of the longest standing filler manufacturers in
the industry, it's a brand I trust due to the years of clinical
studies and safety data available to help me feel confident in the
product I'm offering to my patients. Even the JUVÉDERM®
syringe itself is innovative – it's the first and only certified
ergonomic syringe that helps minimize hand fatigue so I can
comfortably treat patients all day long. JUVÉDERM®
enables me to offer my patients a suite of premium products that
deliver smooth, natural-looking, and long-lasting
results6-12 so my patients keep coming back time and
again."
About the JUVÉDERM® Double Points
Promotion
Consumers can experience the JUVÉDERM®
difference while earning double points in Allē towards a future
JUVÉDERM® or other Allē eligible treatment when treated
with two or three syringes from the JUVÉDERM® Collection
of Fillers during the same visit through Friday, September 30, 2022. Consumers who take
the challenge and experience the JUVÉDERM® difference
will be treated with products that are:
- Long-Lasting: JUVÉDERM® Ultra Plus XC
and JUVÉDERM® VOLLURE® XC are the
longest-lasting dermal fillers FDA approved to treat moderate to
severe facial wrinkles and folds.7,8 Plus, with optimal
treatment, JUVÉDERM® VOLUMA® XC can last up
to two years in the cheeks, two times longer than any other
hyaluronic acid (HA) cheek filler.13-15
- Natural Looking and Feeling: Specific to lip treatment,
both JUVÉDERM® Ultra XC and JUVÉDERM®
VOLBELLA® XC provide natural-looking and natural-feeling
results.6, 10
- Instant Results: The full collection of
JUVÉDERM® Fillers offers immediate results, from lips
and lines to cheeks and chin.6-12
- Minimally Invasive: Every HA filler product in the
JUVÉDERM® Collection of Fillers is FDA approved to be
safe and effective. HA is a naturally occurring substance that
delivers volume to the skin. JUVÉDERM® is a non-surgical
option that contains a modified form of HA.
Consumers are encouraged to enroll in Allē to unlock access to
the current promotion, subject to applicable program terms and
conditions. Allē is the first and only loyalty program in the
aesthetics market to also offer consumers the ability to earn
points on over 40 non-Allergan Aesthetics treatments and brands. To
learn more about Allē, visit Alle.com.
For more information on the JUVÉDERM® Collection of
Fillers, visit Juvéderm.com, follow @JUVÉDERM on Instagram and
subscribe to the JUVÉDERM® Collection of Fillers channel
on YouTube.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information, visit
www.AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com. Follow
@abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
JUVÉDERM® Injectable Gel Fillers
Important Information
APPROVED USES
JUVÉDERM® VOLUMA® XC injectable gel is for
deep injection in the cheek area to correct age-related volume loss
and for augmentation of the chin region to improve the chin profile
in adults over 21.
JUVÉDERM® VOLUX™ XC injectable gel is for deep
injection to improve moderate to severe loss of jawline definition
in adults over the age of 21.
JUVÉDERM® VOLLURE® XC,
JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra
XC injectable gels are for injection into the facial tissue for the
correction of moderate to severe facial wrinkles and folds, such as
nasolabial folds. JUVÉDERM® VOLLURE® XC
injectable gel is for adults over 21.
JUVÉDERM® Ultra XC injectable gel is also for
injection into the lips and perioral area for lip augmentation in
adults over 21.
JUVÉDERM® VOLBELLA® XC injectable gel is
indicated for injection into the lips for lip augmentation and
correction of perioral lines, and for injection into the undereye
hollows to improve the appearance of undereye hollows in adults
over the age of 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any
JUVÉDERM® formulation?
Do not use
these products if you have a history of multiple severe allergies
or severe allergic reactions (anaphylaxis), or if you are allergic
to lidocaine or the Gram-positive bacterial proteins used in these
products, or if you have had previous allergic reactions to
hyaluronic acid fillers.
What warnings should my doctor advise me about?
- One of the risks with using dermal fillers is the unintentional
injection into a blood vessel. The chances of this happening are
very small, but if it does happen, the complications can be serious
and may be permanent. These complications, which have been reported
for facial injections, can include vision abnormalities, blindness,
stroke, temporary scabs, or permanent scarring of the skin. Most of
these events are irreversible.
- The use of dermal fillers where skin sores, pimples, rashes,
hives, cysts, or infections are present should be postponed, as
this may delay healing or make skin problems worse.
- The effectiveness of removal of any dermal filler has not been
studied.
What precautions should my doctor advise me about?
- JUVÉDERM® VOLBELLA® XC should only be
injected into undereye hollows by doctors who have completed the
necessary training for this treatment area. To find a doctor, visit
Juvederm.com/find-a-specialist. Doctors who complete the training
will be listed with a symbol
- The safety of these products for use during pregnancy or while
breastfeeding has not been studied
- The safety of JUVÉDERM® VOLUMA® XC has
not been studied in patients under 35 years or over 65 years for
cheek augmentation, or under 22 years and over 80 years for chin
augmentation. The safety of JUVÉDERM® VOLUX™ XC,
JUVÉDERM® VOLLURE® XC and
JUVÉDERM® VOLBELLA® XC has not been studied
in patients under 22 years, and the safety of JUVÉDERM®
Ultra Plus XC and JUVÉDERM® Ultra XC has not been
studied in patients under 18 years
- The safety and effectiveness of treatment with
JUVÉDERM® products in anatomical regions outside of
their approved uses have not been established in clinical
studies
- If you have a history of excessive scarring (thick, hard scars)
or pigmentation disorders, treatment in these patients has not been
studied and may result in additional scars or changes in
pigmentation
- If you are planning other procedures including laser treatments
or a chemical peel, there is a possible risk of inflammation at the
treatment site if these procedures are performed closely before or
after JUVÉDERM® injectable gel treatment
- Tell your doctor if you are on therapy used to reduce your
body's natural defense system (such as steroids, chemotherapy, and
medicines to treat autoimmune diseases, HIV, and AIDs), as these
may increase your risk of infection; and medications that can
prolong bleeding (such as aspirin, ibuprofen, or other blood
thinners), as these may result in increased bruising or bleeding at
the injection site
- Minimize strenuous exercise, exposure to extensive sun or heat,
and alcoholic beverages within the first 24 hours following
treatment, as these may cause temporary redness, swelling, and/or
itching at the injection site
- JUVÉDERM® VOLUMA® XC was not studied in
patients with significant loose skin of the chin, neck, or jaw
- The effect of JUVÉDERM® VOLUMA® XC
injection into the chin on facial hair growth has not been
studied
- Patients who experience skin injury near the site of
JUVÉDERM® VOLUMA® XC injection may be at a
higher risk for adverse events
- Tell your doctor if you have already been injected with dermal
fillers in the same area as the one(s) you are about to be treated
for. This information helps your doctor decide when and whether you
should get treatment
What are possible side effects of treatment?
The most
commonly reported side effects with JUVÉDERM® injectable
gels were redness, swelling, pain, tenderness, firmness,
lumps/bumps, bruising, discoloration, and itching. For
JUVÉDERM® VOLBELLA® XC, dryness was also
reported.
These side effects are consistent with other facial injection
procedures, and most will resolve with time. Your doctor may choose
to treat side effects persisting over 30 days with antibiotics,
steroids, or hyaluronidase (an enzyme that breaks down hyaluronic
acid).
As with all skin injection procedures, there is a risk of
infection.
To report a side effect with any product in the
JUVÉDERM® Collection, please call the
Allergan® Product Support Department at
1‑877‑345‑5372. Please also visit Juvederm.com or talk to your
doctor for more information.
Products in the JUVÉDERM® Collection are available
only by a licensed physician or properly licensed practitioner.
References
- Allergan Data on File, Filler Situational Analysis, 2020.
- Allergan Data on File, Filler Situation Analysis, 2021.
- Allergan Data On File JUVÉDERM® Ultra XC Directions
for Use 2020.
- Allergan Data On File JUVÉDERM® Ultra Plus XC
Directions for Use 2020.
- Allergan Data On File JUVÉDERM® VOLLURE®
XC Directions for Use 2020.
- Allergan Data On File JUVÉDERM® Ultra XC Patient
Label 2020.
- Allergan Data On File JUVÉDERM® Ultra Plus XC
Patient Label 2020.
- Allergan Data On File JUVÉDERM® VOLLURE®
XC Patient Label 2020.
- Allergan Data on File JUVÉDERM® VOLUMA®
XC Patient Label 2020.
- Allergan Data on File JUVÉDERM® VOLBELLA®
XC Patient Label 2020.
- Allergan Data on File JUVÉDERM® VOLUMA®
XC Patient Label 2020.
- Allergan Data on File JUVÉDERM® VOLUX™ XC
Patient Label 2022.
- Allergan Data On File JUVÉDERM® VOLUMA®
XC Directions for Use 2020.
- RESTYLANE® LYFT™ IFU May
2020.
- RESTYLANE® Contour IFU June
2021.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/experience-the-juvederm-difference-with-allergan-aesthetics-301607369.html
SOURCE AbbVie